Synergistic combinations of polymyxins

JR Lenhard, RL Nation, BT Tsuji - International journal of antimicrobial …, 2016 - Elsevier
The proliferation of extensively drug-resistant Gram-negative pathogens has necessitated
the therapeutic use of colistin and polymyxin B. However, treatment failures with polymyxin …

In Vivo and In Vitro Efficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii

YS Yang, Y Lee, KC Tseng, WC Huang… - Antimicrobial agents …, 2016 - Am Soc Microbiol
Minocycline-based combination therapy has been suggested to be a possible choice for the
treatment of infections caused by minocycline-susceptible Acinetobacter baumannii, but its …

From Natural products to drugs: Glyco-and lipoglycopeptides, a new generation of potent cell wall biosynthesis inhibitors

S Biondi, E Chugunova, M Panunzio - Studies in Natural Products …, 2016 - Elsevier
Abstract “… Antibiotic resistance-when bacteria change and antibiotics fail-is happening
right now, across the world… without urgent action we are heading for a post antibiotic era in …

Pseudomonas Aeruginosa: Targeting Cell-Wall Metabolism for New Antibacterial Discovery and Development

RP Lamers, LL Burrows - Future Medicinal Chemistry, 2016 - Taylor & Francis
Pseudomonas aeruginosa is a leading cause of hospital-acquired infections and is resistant
to most antibiotics. With therapeutic options against P. aeruginosa dwindling, and the lack of …

[PDF][PDF] Effective in Vitro Synergy of Piperacillin/Tazobactam Plus either Netilmicin or Aztreonam against Metallo-β-lactamase-producing Pseudomonas Aeruginosa

WH Amer, M Mohamed… - Univers J Microbiol Res, 2016 - researchgate.net
This study was designed to compare the activity of piperacillin/tazobactam (TZP) in
combination with either netilmicin (NET) or aztreonam (ATM) against metallo-β lactamases …

[引用][C] Future Medicinal Chemistry

RP Lamers, L Lori